Kathy Bloomgarden

Chief Executive Officer, Ruder Finn

Dr. Kathy Bloomgarden is CEO of Ruder Finn, one of the world’s largest independent global communications and integrated marketing agencies. With a forward-thinking approach, Bloomgarden has built an agency for the future. She has decades of experience shaping communications that move industry-defining brands, companies, and leaders from what’s now to what’s next. She has built rf.TechLab, one of the industry’s most dynamic in-house tech incubators, that specializes in developing tools and solutions to help brands leverage emerging technologies in data science, modeling, machine learning, AI, and more to solve complex business challenges. Under Bloomgarden’s leadership, TechLab quickly became the catalyst behind a series of industry first innovations, including rf.aio, the first agency GEO tool, and rf.Studio53, Ruder Finn’s AI-powered creative studio.

Bloomgarden is a recognized voice in leadership circles including the World Economic Forum, Fortune CEO Council, WSJ CEO Council, the Council on Foreign Relations, and the Partnership for New York, as well as an incoming member of the PRWeek Hall of Fame, one of the industry’s more prestigious distinctions, and the International Communications Consultancy Organization Hall of Fame. More of her recent recognitions include PR Agency Leader at the Campaign Agency of the Year Global Awards, Agency Global Professional at the PRWeek Global Awards, Outstanding Individual Achievement award at the PRovoke Media Sabre Awards, and a 2025 Pinnacle Award Honoree at the MM+M Pinnacle Awards.

Bloomgarden authored "Trust: The Secret Weapon of Effective Business Leaders" and holds a B.A. in Political Science and French from Brown University, and a PhD and M.A. in Political Science and Chinese from the Columbia University School for International Studies.

Most Popular

Health and Healthcare Systems

インテリジェント時代におけるヘルスケアの改善には、文化の変革と協力が不可欠

医療に人工知能(AI)を導入するためには、協力、オープンな姿勢、そして時代遅れのワークフローの変革を優先する、マインドセットの転換が必要です。AIを活用したツールは、オーダーメイド治療を提供する一方、その効果を最大限に引き出すためには、患者の関与とデータの同意が不可欠です。

26 Dec 2024

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2026 World Economic Forum